ArticleThe oncologist2020
Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.
Ran Huo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleThe oncologist2020
Ran Huo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.